Actively Recruiting
Effect of Vitamin D3 on Brain Waves in Male Parkinson's Patients With Low Vitamin D: A qEEG Study
Led by Bangladesh Medical University · Updated on 2025-07-31
15
Participants Needed
1
Research Sites
15 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an experimental study (Interventional self-controlled trial, pretest-posttest design). The goal of this clinical trial is to evaluate the effect of vitamin D3 supplementation on quantitative EEG in male Parkinson's disease patients with hypovitaminosis D. The main question it aims to answer is: Vitamin D3 supplementation has effect on brain waves in male Parkinson's disease patients with hypovitaminosis D. Researcher will compare the effect of vitamin D3 supplementation on brain waves in male Parkinson's disease patients with hypovitaminosis D with their pre intervention ( baseline ) condition on brain waves to assess whether there will be any improvement of brain electrical activity by quantitative electroencephalogram (QEEG). Participants will : Take vitamin D3 orally for 8 weeks (50,000 IU/week) Visit the medical university after 8 weeks for evaluation of serum 25(OH)D level and QEEG Must bring the empty strips of vitamin D supplement with them during their visit.
CONDITIONS
Official Title
Effect of Vitamin D3 on Brain Waves in Male Parkinson's Patients With Low Vitamin D: A qEEG Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male patients with Parkinson's disease up to stage 3 according to Hoehn and Yahr scale
- Aged 51 to 70 years
- Body mass index (BMI) between 18.5 and 24.9 kg/m2
- Confirmed hypovitaminosis D with serum 25(OH)D level below 30 ng/ml
- Currently on Levodopa therapy
You will not qualify if you...
- Already taking vitamin D3 supplements
- Using medications or substances affecting neuronal excitability or EEG, including sedatives, antidepressants, antipsychotics, or alcohol
- Currently suffering from neurological disorders such as migraine or epilepsy
- Currently suffering from cardiovascular disorders including myocardial infarction, hypertension, cardiac arrhythmia, or heart failure
- Currently suffering from respiratory disorders such as bronchial asthma or COPD
- Diagnosed psychiatric illnesses including schizophrenia, major depression, bipolar disorder, or severe dementia
- Biochemical evidence of hypercalcemia, renal insufficiency, liver diseases, or uncontrolled endocrine disorders like diabetes mellitus, hypothyroidism, or hyperthyroidism
- Active smoker
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Bangladesh medical university
Dhaka, Shahbag, Bangladesh, 1000
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here